Diabetes, insulin and new therapeutic strategies for Parkinson's disease: Focus on glucagon-like peptide-1 receptor agonists

  1. Labandeira, C.M.
  2. Fraga-Bau, A.
  3. Arias Ron, D.
  4. Muñoz, A.
  5. Alonso-Losada, G.
  6. Koukoulis, A.
  7. Romero-Lopez, J.
  8. Rodriguez-Perez, A.I.
Journal:
Frontiers in Neuroendocrinology

ISSN: 1095-6808,  0091-3022

Year of publication: 2021

Volume: 62

Type: Review

DOI: 10.1016/J.YFRNE.2021.100914 GOOGLE SCHOLAR

Sustainable development goals

Data source: Scopus